Poziotinib
Poziotinib is an orally bioavailable, quinazoline-based pan-epidermal growth factor receptor (EGFR or HER) inhibitor with potential anti-tumor activity. HM781-36B irreversibly inhibits EGFR (HER1 or ErbB1), including EGFR mutants, HER2, and HER4, thereby inhibiting the proliferation of tumor cells overexpressing these receptors.
| Supplier | Alfa Cytology |
|---|---|
| Product # | BC0422 |
| Pricing | 10.0 mg, 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, 500.0 mg, 1.0 g, 2.0 g, inquire |